linkedin

Resource Library

Whitepapers

β-glucan as a Process-Related Impurity in Biopharmaceuticals

WHITRPAPER

WHITEPAPER

β-glucan as a
Process-Related Impurity in
Biopharmaceuticals
Soonbin Kwon
Senior Scientist, MSAT


 

 

Global regulatory authorities and #CDMOs are taking steps to detect beta-glucans as well as understand their safety levels. When introduced into biopharma drug products via raw materials in the manufacturing process, beta-glucan impurities can lead to batch recalls and other quality issues. In this whitepaper, Soonbin Kwon, our Senior Scientist in MSAT, explores the source of the beta-glucan impurity, its influence on manufacturing and patient safety, and strategies to detect and control its amounts in the final drug product. 

WHITRPAPER

WHITRPAPER

β-glucan as a
Process-Related Impurity in
Biopharmaceuticals
Soonbin Kwon
Senior Scientist, MSAT

 

Global regulatory authorities and #CDMOs are taking steps to detect beta-glucans as well as understand their safety levels. When introduced into biopharma drug products via raw materials in the manufacturing process, beta-glucan impurities can lead to batch recalls and other quality issues. In this whitepaper, Soonbin Kwon, our Senior Scientist in MSAT, explores the source of the beta-glucan impurity, its influence on manufacturing and patient safety, and strategies to detect and control its amounts in the final drug product.
 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved